Natalie Ramirez, OD
Optometrist · Waipahu, HINPI 1487094454
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 61 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 42.3% of the total.
Across 61 payments — averaging $67.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$2K
- Coopervision Inc.$369
- Alcon$366
- Tarsus Pharmaceuticals, Inc.$347
- Bausch & Lomb, A Division Of Bausch Health US, LLC$227
- Amgen$186
- plus $889 from 9 others
What the payments were for
- Food & beverage$4,131100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 20 | $1,746 |
| Coopervision Inc. | 3 | $369 |
| Alcon | 8 | $366 |
| Tarsus Pharmaceuticals, Inc. | 6 | $347 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $227 |
| Amgen(2 entities) | 3 | $186 |
| Glaukos Corporation | 1 | $155 |
| AbbVie | 5 | $134 |
| LKC Technologies, Inc. | 1 | $134 |
| Johnson & Johnson Vision Care, Inc. | 6 | $128 |
| Aerie Pharmaceuticals, Inc. | 1 | $122 |
| Carl Zeiss Meditec USA, Inc. | 1 | $114 |
| Sun Pharmaceutical Industries Inc. | 2 | $64 |
| Lombart Brothers, Inc. | 1 | $25 |
| Thea Pharma Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFUSE$995
- BIOTRUE ONE DAY$741
- MyDay Contact Lens$369
- KXL System$155
- Photrexa$155
- INFUSE SVS$150
- Hydrus Microstent$148
- TEPEZZA$138
- VYZULTA$125
- MIEBO$125
- XIIDRA$125
- LOTEMAX SM$123
- Rhopressa$122
- Rocklatan$122
- XDEMVY$118
- FORUM$114
How this compares
$4,131 in reported general payments places this provider in the 80th percentile of 310 optometrist providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 20 | $12,746 |
| VyzultaLatanoprostene Bunod | 19 | $10,502 |
| MieboPerfluorohexyloctane/Pf | 14 | $10,476 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 15 | $3,117 |
| Latanoprost | 57 | $1,283 |
| Prednisolone Acetate | 12 | $408 |
| Azelastine Hcl | 11 | $279 |
| Timolol Maleate | 12 | $63 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bausch & Lomb Americas Inc.Vyzulta, Miebo | $1,746 | $20,97833 claims |
| AbbVieLumigan | $134 | $12,74620 claims |
| AlconSimbrinza | $366 | $3,11715 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 310 optometrist providers in Hawaii.
Other optometrist in Waipahu
- Jon IshiharaWaipahu$13K
- Kathy IshimotoWaipahu$8K
- Camie Nakagawa-KakudaWaipahu$7K
- Linda ArakakiWaipahu$6K
- Darrah WongWaipahu$5K
- Grant MiyashiroHilo$26K
- Jana SouzaHilo$16K
- Geoffrey ReynoldsMililani$14K
- Patricia IchimuraHonolulu$11K
- Lillian TakamuraHonolulu$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.